Photo: web

The first set of independently developed nuclear cancer therapy built by China National Nuclear Group (CNNC) is set to be deployed in a hospital in Tai 'an, East China’s Shandong Province. The development marks an important step toward the trialing and market application of the treatment and latest achievement in China’s local capability linked to high-end medical equipment.

The China Institute of Atomic Energy of CNNC signed a cooperation agreement with Tai'an Central Hospital of Shandong Province for use of Boron neutron capture therapy (BNCT) treatment on Thursday.

According to the cooperation agreement, China Institute of Atomic Energy will provide a set of BNCT cancer treatment to Tai'an Central Hospital. The BNCT treatment center is expected to be constructed in June 2024 and be ready for operation in June 2026.

BNCT is a most cutting-edge targeted cancer therapy technology in the field of international tumor therapy to emerge in recent years. It is often used in the treatment of head and neck cancer, and melanoma.

On November 25, the China Institute of Atomic Energy achieved the breakthrough of the key technologies in the development of BNCT cancer treatment.

According to China Institute of Atomic Energy, the treatment is low in cost and can be operated and maintained at a relative low cost. It can be used for cancer treatment and also for the production of radioisotope drugs.

Global Times